DAWEX
22.4.2024 08:31:26 CEST | Business Wire | Press release
Data4Industry-X, the trusted data exchange solution for Industry, carries on its dynamics to bring the most comprehensive and flexible solution on the market for industrial organizations aiming at boosting competitiveness and minimizing carbon footprint. Recognized as a Gaia-X Lighthouse project and contributing to the Manufacturing-X initiative, the Data4Industry-X solution is designed to accelerate data & information exchange between global organizations, subsidiaries and suppliers by leveraging the most advanced, secure and compliant data exchange technology on the market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240421440918/en/
Supported by the AIF (Alliance pour l’industrie du futur), and initially responding to the power generation and automotive markets, Data4Industry-X gathers technological & industrial expertise from Dawex, Schneider Electric, Valeo, CEA, and Prosyst, in order to deliver broad cross-border, cross-company, cross-factory industrial data exchanges.
Industrial organizations with plants, shop floors and suppliers, spread across the globe with decentralized manufacturing, are concerned by their ability to bring innovations and operational efficiencies to increase competitiveness, while reducing CO2 emissions to meet and report on their sustainability obligations.
With the objective to support the digital transformation of all industry stakeholders and create a compelling industry data ecosystem encompassing all sizes of organizations, Data4Industry-X solution relies on Dawex Data Exchange technology. The solution is based on open and cloud-agnostic architecture, to deliver a trusted, secure, sovereign and compliant data exchange environment that implements the Gaia-X de facto standards. Powered by this technology, the Data4Industry-X solution will use the Eclipse Dataspace Component framework to facilitate interoperability between data spaces. Additionally, thanks to the UDC (Unified Data Collector) Prosyst solution, Data4Industry-X interfaces with OPC UA protocol to retrieve industrial data and exchange them at scale with the broad ecosystem.
By relying on technological and industrial expertise, Data4Industry-X becomes the most agnostic, flexible and advanced data exchange solution for Industry, designed in compliance with the new European data regulations, such as the Data Act and the Data Governance Act, capable of operating in any industrial situation, with all types of companies.
The Data4Industry-X solution will bridge the entire industry data ecosystem by enabling large and small organizations in all sectors to exchange, distribute and valorize industrial data, securely, to ultimately improve operational efficiency and meet decarbonation objectives.
“Data4Industry-X pursues its dynamics to deploy the most advanced data exchange solution for the industry to accelerate innovation, better control carbon footprint, and gain competitive advantage thanks to data circulation.” said Laurent Lafaye, co-CEO at Dawex. “Data4Industry-X will ultimately empower all industry stakeholders, of all sizes, to engage into data exchange and contribute to fostering a resilient and sustainable industry ecosystem by benefiting from the full potential of data”.
Data4Industry-X is supported by the French government’s France 2030 initiative and the European program Next Generation.
About Dawex
About Schneider Electric
About Valeo
About CEA-List
About Prosyst
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240421440918/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press release
Trial reports correlations between ketone levels and cognitive and psychiatric symptoms in individuals with schizophrenia-spectrum and bipolar-1 disorders Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.co
Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press release
Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents
Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press release
Oversubscribed round follows the world-first compact upright proton treatment at Stanford Medicine — funding a single upright platform that will span imaging and treatment across multiple radiation modalities. Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and
LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press release
The Halocene H4 quantum computer, named LUMI-IQ, will be delivered and installed in 2027 The system will be hosted at CSC – IT Center for Science in Finland and integrated into the LUMI AI Factory The system will provide researchers, industry innovators, and developers across Europe with a unique, advanced experimental platform where quantum computing and artificial intelligence converge The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer o
Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations8.7.2026 14:00:00 CEST | Press release
Enpatoran could address a significant unmet need in lupus, specifically targeting cutaneous manifestations of the disease, which currently have no approved therapiesFDA's decision was supported by Phase 2 WILLOW study results, which demonstrated meaningful symptoms improvement, particularly among patients with active cutaneous manifestationsEnpatoran's potential to go beyond current treatment standards in lupus prompted FDA´s breakthrough designation, which is designed to expedite drug development and reviewNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus with active cutaneous manifestations. Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor, designed to modulate pathways central to lupus-related inflammation. “For the 85% of lupus patients whose disease includes skin manif
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom